Related references
Note: Only part of the references are listed.Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP)
Jae Seung Kang et al.
GUT AND LIVER (2021)
Accuracy of long-form data in the Taiwan cancer registry
Chia-Wen Kao et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2021)
Recurrence in Patients Achieving Pathological Complete Response After Neoadjuvant Treatment for Advanced Pancreatic Cancer
Alex B. Blair et al.
ANNALS OF SURGERY (2021)
Colorectal cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
The American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma: is it better than the 7th edition?
Dong Woo Shin et al.
HEPATOBILIARY SURGERY AND NUTRITION (2020)
Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
Panagiotis Sarantis et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)
Significance of Lymph Node Resection After Neoadjuvant Therapy in Pancreatic, Gastric, and Rectal Cancers
Amanda K. Arrington et al.
ANNALS OF SURGERY (2020)
Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma
Giampaolo Perri et al.
JAMA SURGERY (2020)
Cancer Incidence Characteristic Evolution Based on the National Cancer Registry in Taiwan
Yu-Ching Huang et al.
JOURNAL OF ONCOLOGY (2020)
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment
Stijn van Roessel et al.
JAMA ONCOLOGY (2020)
Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection
Georgios Gemenetzis et al.
ANNALS OF SURGERY (2019)
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches
Michael Orth et al.
RADIATION ONCOLOGY (2019)
Adjuvant chemotherapy after surgery for pancreatic ductal adenocarcinoma: retrospective real-life data
Sophia Chikhladze et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)
A Quantitative Clinicopathological Signature for Predicting Recurrence Risk of Pancreatic Ductal Adenocarcinoma After Radical Resection
Chaobin He et al.
FRONTIERS IN ONCOLOGY (2019)
Development of a prediction model for breast cancer based on the national cancer registry in Taiwan
Ching-Chieh Huang et al.
BREAST CANCER RESEARCH (2019)
Is quality of registry treatment data related to registrar experience and workload? A study of Taiwan cancer registry data
Chin-Ying Cheng et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2018)
Stage III should be subclassified into Stage III A and III B in the American Joint Committee on Cancer (8th Edition) staging system for pancreatic cancer
Hai-Feng Yu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Benefit from the inclusion of surgery in the treatment of patients with stage III pancreatic cancer: a propensity-adjusted, population-based SEER analysis
Lai Wang et al.
Cancer Management and Research (2018)
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer
Stijn van Roessel et al.
JAMA SURGERY (2018)
The New American Joint Committee on Cancer TNM Staging System for Pancreatic Cancer-Balancing Usefulness With Prognostication
Colin M. Court et al.
JAMA SURGERY (2018)
Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for Tand N Staging in Patients With Pancreatic Adenocarcinoma
Peter J. Allen et al.
ANNALS OF SURGERY (2017)
Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis
Sivesh K. Kamarajah et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor grade: a recursive partitioning analysis
Yu-Tong Chen et al.
MEDICAL ONCOLOGY (2016)
Epidemiology of pancreatic cancer
Milena Ilic et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review
Chun-Ju Chiang et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2015)
Update on the management of pancreatic cancer: Surgery is not enough
Daniel Ansari et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
The Incidence and Survival Rate of Population-Based Pancreatic Cancer Patients: Shanghai Cancer Registry 2004-2009
Jianfeng Luo et al.
PLOS ONE (2013)
Pancreatic adenocarcinoma
Giles Bond-Smith et al.
BRITISH MEDICAL JOURNAL (2012)
Concordance probability and discriminatory power in proportional hazards regression
M Gönen et al.
BIOMETRIKA (2005)
Time-dependent ROC curves for censored survival data and a diagnostic marker
PJ Heagerty et al.
BIOMETRICS (2000)
Share Paper
